中国临床新医学
中國臨床新醫學
중국림상신의학
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
2009年
7期
751-752
,共2页
社区获得性肺炎%病原菌%耐药性
社區穫得性肺炎%病原菌%耐藥性
사구획득성폐염%병원균%내약성
Community-acquired pneumonia%Pathogens%Drug resistance
目的 了解社区获得性肺炎(CAP)的病原菌分布及耐药情况,为合理使用抗生素提供依据.方法 收集2007-03~2008-06发病的50例社区获得性肺炎患者的痰液,做常规细菌培养鉴定,用NCCL2005推荐指南的K-B纸片法进行体外药敏试验.结果 病原菌中革兰氏阴性菌占74%,革兰氏阴性菌对头孢唑啉、氨苄西林、环丙沙星耐药较为突出,对阿米卡星敏感;革兰氏阳性菌对青霉素、红霉素、阿莫西林的耐药较为突出,对头孢吡肟、万古霉素敏感.结论 临床治疗应重视病原菌检测及耐药试验,为临床合理使用抗生素提供依据,预防细菌耐药性增加,提高治愈率,降低医药费.
目的 瞭解社區穫得性肺炎(CAP)的病原菌分佈及耐藥情況,為閤理使用抗生素提供依據.方法 收集2007-03~2008-06髮病的50例社區穫得性肺炎患者的痰液,做常規細菌培養鑒定,用NCCL2005推薦指南的K-B紙片法進行體外藥敏試驗.結果 病原菌中革蘭氏陰性菌佔74%,革蘭氏陰性菌對頭孢唑啉、氨芐西林、環丙沙星耐藥較為突齣,對阿米卡星敏感;革蘭氏暘性菌對青黴素、紅黴素、阿莫西林的耐藥較為突齣,對頭孢吡肟、萬古黴素敏感.結論 臨床治療應重視病原菌檢測及耐藥試驗,為臨床閤理使用抗生素提供依據,預防細菌耐藥性增加,提高治愈率,降低醫藥費.
목적 료해사구획득성폐염(CAP)적병원균분포급내약정황,위합리사용항생소제공의거.방법 수집2007-03~2008-06발병적50례사구획득성폐염환자적담액,주상규세균배양감정,용NCCL2005추천지남적K-B지편법진행체외약민시험.결과 병원균중혁란씨음성균점74%,혁란씨음성균대두포서람、안변서림、배병사성내약교위돌출,대아미잡성민감;혁란씨양성균대청매소、홍매소、아막서림적내약교위돌출,대두포필우、만고매소민감.결론 림상치료응중시병원균검측급내약시험,위림상합리사용항생소제공의거,예방세균내약성증가,제고치유솔,강저의약비.
Objective To understand the pathogen distribution and drug resistance of community-acquired pneumonia (CAP), in order to provide the basis for the rational use of antibiotics.Methods From March 1, 2007 to June 1,2008 the sputum from 50 cases of community-acquired pneumonia were collected for conventional bacterial culture and for drug sensitive test, with guidelines recommended NCCL2005 paper KB vitro method.Results In the pathogens, resistance of gram-negative bacteria (74%) to cefazolin, ampicillin, ciprofloxacin is more prominent, sensitive to amikacin;resistance of gram-positive bacteria to penicillin, erythromycin, amoxicillin is more prominent, sensitive to cefepime, vancomycin.Conclusion The clinical treatment should pay attention to pathogen detection and resistance test, in order to provide the clinical basis for the rational use of antibiotics to prevent bacterial resistance, increase the cure rate and reduce medical expenses.